P. Żelazny, “Angiotensin Receptor Antagonist-Neprilysin Inhibitor (ARNI) therapy as a new hope in the population of people with heart failure with reduced ejection fraction (HFrEF)”, J Educ Health Sport, vol. 12, no. 9, pp. 583–588, Sep. 2022.